Barbara S. Schilberg

Barbara S. Schilberg

Direktor/Vorstandsmitglied bei Jenrin Discovery LLC

Health Technology
Consumer Services
Finance

Profil

Prior to joining BioAdvance, Ms. Schilberg developed years of experience in the biopharmaceutical industry.
Her experience in senior management started in 1994 when she joined Cephalon as Senior Vice President and General Counsel and as a member of the executive committee.
As part of her responsibilities, she led a multi-disciplinary team charged with completing Phase III clinical trials and preparing a new drug application for PROVIGIL, which was approved by the FDA in December 1999.
Ms. Schilberg joined Incara Pharmaceuticals in 1998 as Executive Vice President and General Counsel, where she managed a research operation in Princeton, NJ engaged in discovering new antibacterial therapeutics.
She also served as Vice President and General Counsel at Locus Discovery, Inc., an emerging pharmaceutical company in Blue Bell, PA engaged in computational drug design.
Before joining the industry, she specialized in representing biopharmaceutical companies and research institutions in the commercialization of technology.
Before joining industry, Ms. Schilberg specialized in representing biopharmaceutical companies and research institutions in the commercialization of technology, as a partner in the Philadelphia office of Morgan, Lewis & Bockius.
There she developed novel strategies for the licensing and commercialization of life sciences technology on behalf of biopharmaceutical companies such as Cephalon, Inc. and non-profit research institutions such as the University of Pennsylvania, The Wistar Institute and Thomas Jefferson University.
Her practice supported a wide range of industry activities, including venture capital financings, IPOs and other public offerings, marketing, co-development and joint-venture arrangements, sponsored research, and technology transfer.
Ms. Schilberg received her J.D.
from the University of Virginia and clerked with the Honorable Edward R.
Becker, now Senior Judge of the U.S.
Court of Appeals for the Third Circuit.

Aktive Positionen von Barbara S. Schilberg

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 11.01.2010
Direktor/Vorstandsmitglied -
Alle aktiven Positionen von Barbara S. Schilberg

Ehemalige bekannte Positionen von Barbara S. Schilberg

UnternehmenPositionEnde
Vorstandsvorsitzender 30.09.2021
Corporate Officer/Principal 31.12.1997
ANNOVIS BIO, INC. Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Barbara S. Schilberg im Detail an

Ausbildung von Barbara S. Schilberg

University of Virginia Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Barbara S. Schilberg im Detail an

Beziehungen

21

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
ANNOVIS BIO, INC.

Health Technology

Private Unternehmen8

Health Technology

Incara Pharmaceuticals Corp.

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Barbara S. Schilberg